Literature DB >> 11902551

The role of the coagulation system in tumour angiogenesis.

G F Nash1, D C Walsh, A K Kakkar.   

Abstract

The coagulation system, which is activated in most cancer patients, has an important role in tumour biology. It may make a substantial contribution to tumour angiogenesis, which represents an imbalance in the normal mechanisms that allow organised healing after injury. The recently recognised, but steadily growing, knowledge of the relationship between the coagulation and angiogenesis pathways has research and clinical implications. Manipulation of these systems may minimise both the neoangiogenesis essential for tumour growth and associated thromboembolic complications. However, since surgery is the primary treatment for most cancers, the angiogenesis of wound healing and haemostatic competence must be maintained. In this article, we summarise the complex interactions between the coagulation system and the angiogenic process that occur in cancer growth. We focus upon the contributions of the vascular endothelium, platelets, and coagulation factors to the angiogenic process and explore the coagulation system as a therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11902551     DOI: 10.1016/s1470-2045(01)00518-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  19 in total

1.  Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets.

Authors:  Li Ma; Rafael Perini; Webb McKnight; Michael Dicay; Andre Klein; Morley D Hollenberg; John L Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

2.  Diminution in adenine nucleotide hydrolysis by platelets and serum from rats submitted to Walker 256 tumour.

Authors:  Andréia Buffon; Vanessa B Ribeiro; Alessandra S Schanoski; João J F Sarkis
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

3.  Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.

Authors:  James R Cerhan; Stephen M Ansell; Zachary S Fredericksen; Neil E Kay; Mark Liebow; Timothy G Call; Ahmet Dogan; Julie M Cunningham; Alice H Wang; Wen Liu-Mares; William R Macon; Diane Jelinek; Thomas E Witzig; Thomas M Habermann; Susan L Slager
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

4.  Serum VEGF, blood transfusion, and wound orientation : Letter re: Belizon et al. Surg Endosc. 2008 Jan 18.

Authors:  G F Nash
Journal:  Surg Endosc       Date:  2008-07-23       Impact factor: 4.584

Review 5.  Roles of platelets and proteinase-activated receptors in gastric ulcer healing.

Authors:  Rafael Perini; John L Wallace; Li Ma
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

6.  The tumor microenvironment in colorectal carcinogenesis.

Authors:  Vijay G Peddareddigari; Dingzhi Wang; Raymond N Dubois
Journal:  Cancer Microenviron       Date:  2010-03-05

7.  Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study.

Authors:  Kellen L Meadows; Christel Rushing; Wanda Honeycutt; Kenneth Latta; Leigh Howard; Christy A Arrowood; Donna Niedzwiecki; Herbert I Hurwitz
Journal:  Support Care Cancer       Date:  2014-10-24       Impact factor: 3.603

8.  Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Nandor Gabor Than; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Francesca Gotsch; Pooja Mittal; Zhong Dong; Tinnakorn Chaiworapongsa; Chong Jai Kim; Chia-Ling Nhan-Chang; Sun Kwon Kim; Lami Yeo; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-19

9.  Quantitative estimation of Serum Fibrinogen Degradation Product levels in Oral Premalignant and Malignant lesions.

Authors:  Leena Gharat; Govind P Rathod; Shilpa Kandalgaonkar
Journal:  J Int Oral Health       Date:  2013-10-26

10.  Idiopathic venous thromboembolic disease is associated with a poorer prognosis from subsequent malignancy.

Authors:  A Jones; D L Stockton; A J Simpson; J T Murchison
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.